Close
CDMO Safety Testing 2026
Novotech

Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

GMP Compliance in Analytical Testing and Color Control

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.
- Advertisement -

Clinerion’s RWD RADAR offers daily-updated, aggregate metrics on patient cohorts and the patient journey, including usage of terminologies, covering diagnoses, medications, laboratory tests, and procedures, across the Patient Network Explorer hospital network.

Supporting epidemiological research, RWD RADAR generates patient cohort aggregate metrics, as well as offers metrics on the patient journey, from diagnosis to treatment modalities, and geographically, all based on real-world data available on Clinerion’s Patient Network Explorer platform. Patient cohort aggregate metrics show insights on disease-treatment relationships and disease-disease relationships, and are visualized as Top N lists, ranking the related concepts within a field code with the highest patient hits.

The statistics are based on real-time data and available with timestamps, allowing the generation of an incidence timeline. Data may be visualized aggregated, or geographically mapped, as well as showing gender and age distributions.

RWD RADAR can be used for epidemiology studies to look at disease occurrence, treatment metrics, differences by hospital, region and country, as well as to identify differential treatment groups or cohorts by location, procedure or medication (segmentation by different treatment options and/or by drug/drug class). As Clinerion’s patient network expands, this will provide deep insights into hard-to-find patient groups, locations and countries within the network.

Further developments under development by Clinerion, including the installation of an infrastructure for deployment of artificial intelligence / machine learning (AI/ML) algorithms, will enhance the functionality of Patient Network Explorer in the near future.

Clinerion’s Patient Network Explorer is unique in the landscape of EHR-based real-world data solutions with its footprint in 25 countries around the world, and in offering a combination of multi-dimensional query definition, real-time search across multiple networked electronic health record systems made interoperable by the use of semantic and ontology methods, and a highly scalable hybrid cloud- and federated-local-installation-based platform.

“The metrics and statistics offered under RWD RADAR provide a great insight into the power and value of the data accessible by Patient Network Explorer,” says Andreas Walter, Clinerion CTO. “The new statistical tools give users access to more fine detail to understand disease progression and diagnosis, as well as gain insights on treatment regimens and outcomes. Our new federated machine learning framework will develop and derive more insights from our patient data pools.”

“RWD RADAR is just the first development in the evolution of Patient Network Explorer, as Clinerion capitalizes on the promise of tangible, actionable, valuable real-world insights, derivable from the real-world data on our platform,” says Bar?? Erdo?an, Clinerion CEO. “We continue to develop the capabilities and functionalities of the platform to offer maximum support to our clients in obtaining the full benefit of Clinerion’s hospital network.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.

Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Colorimeters Enhancing Consistency in Pharma Testing

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

Advanced Color Measurement Strengthening Pharma QC

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

GMP Compliance in Analytical Testing and Color Control

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.

Choosing Analytical Instruments for Pharma QC Labs

Selecting the right laboratory equipment is a critical decision that directly impacts the efficiency, accuracy, and compliance of pharmaceutical operations. Evaluating analytical instruments pharma QC requirements involves a deep dive into technical specifications, vendor reliability, and the potential for long-term scalability. By choosing tools that integrate seamlessly with existing digital workflows and international regulatory standards, laboratory managers can ensure that their facility is equipped to handle the rigorous demands of modern drug testing and quality assurance. This strategic approach minimizes operational risk and ensures the delivery of safe and effective medications to patients globally.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »